Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.34 USD | -0.94% | +2.69% | +27.25% |
Apr. 09 | Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating | MT |
Apr. 08 | Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.25% | 4.73B | |
+25.26% | 672B | |
+25.87% | 570B | |
-5.90% | 360B | |
+15.82% | 321B | |
+8.55% | 300B | |
+7.09% | 217B | |
-9.20% | 204B | |
+5.05% | 199B | |
-9.06% | 149B |
- Stock Market
- Equities
- OGN Stock
- News Organon & Co.
- Organon, Samsung Bioepis' Biologics License Application for Humira Biosimilar Accepted for Review by FDA